1. Introduction

Data-driven biosurveillance accountability refers to the legal, ethical, and institutional responsibility of governments, public-health authorities, hospitals, laboratories, biotechnology companies, and technology providers when they collect, analyse, share, or use biological and health-related data to detect, monitor, predict, and control threats to public health.

Biosurveillance may use:

Genomic sequencing of viruses, bacteria, and other pathogens.

Electronic health records and hospital admission data.

Wastewater monitoring and laboratory test results.

Wearable devices, digital health applications, and symptom-reporting systems.

Artificial intelligence (AI) models that predict outbreaks or identify populations at risk.

Travel, mobility, and epidemiological datasets used to track disease transmission.

Accountability becomes essential when these systems produce inaccurate predictions, expose sensitive personal information, discriminate against communities, trigger unjustified restrictions, or fail to detect a genuine public-health emergency.

The central legal question is: Who is responsible when a decision based on biosurveillance data causes harm, and what remedies are available to affected individuals and communities?

The answer depends on the jurisdiction, the entity responsible, the nature of the data, the applicable statutory framework, and whether the challenged action violates privacy, equality, administrative law, professional duties, or constitutional rights.

2. Meaning and scope

The accountability chain

Data collection

Clinical records, pathogen samples, wastewater and mobility data

Data processing and analysis

Sequencing, data linkage, risk scoring and predictive AI

Public-health decision

Warnings, testing, quarantine, resource allocation or targeted interventions

Accountability and remedies

Audit, explanation, independent review, correction, compensation and judicial oversight

Accountability is not confined to the final decision. It extends throughout the entire data lifecycle, from the lawful collection of information to the deletion or archival of records and the review of consequences.

Principal forms of accountability

Legal accountability: Compliance with privacy legislation, public-health laws, constitutional protections, and applicable research or clinical regulations.

Scientific accountability: Validation of data quality, analytical methods, predictive models, and epidemiological conclusions.

Administrative accountability: Proper authorisation, reasoned decision-making, transparent procedures, and review of government action.

Institutional accountability: Clear allocation of duties among laboratories, health departments, data controllers, contractors, and AI vendors.

Ethical accountability: Fair treatment, proportionality, respect for human dignity, and protection of vulnerable populations.

Remedial accountability: Effective complaint mechanisms, independent investigations, correction of records, judicial relief, and compensation where legally available.

3. Legal framework governing biosurveillance accountability

A. Constitutional rights and public-health powers

A government may collect and analyse health information to prevent epidemics, but public-health objectives do not automatically justify every form of surveillance.

The legal assessment generally asks whether the measure:

Has a valid legal basis.

Pursues a legitimate public-health objective.

Is necessary to achieve that objective.

Is proportionate to the risk and does not impose excessive burdens.

Includes safeguards against misuse, unauthorised disclosure, and arbitrary decision-making.

Allows appropriate review and remedies.

These principles are especially important when biosurveillance leads to quarantine, restrictions on movement, compulsory testing, employment consequences, or the identification of particular communities as disease risks.

B. Data protection and confidentiality

Biosurveillance frequently processes sensitive personal information. Depending on the governing law, the responsible organisation may have duties concerning lawful processing, purpose limitation, data minimisation, accuracy, security, retention, disclosure, and individual rights.

A distinction must be made between identifiable health data and genuinely anonymised statistical information. Removing names alone may not sufficiently anonymise genomic or location-linked records, particularly when those records can be combined with other datasets.

C. Scientific and administrative accountability

A public authority cannot necessarily avoid responsibility by saying that an algorithm, laboratory, or private contractor produced the result.

Relevant questions include:

Was the source data reliable and representative?

Was the model independently validated?

Were uncertainty and false-positive rates considered?

Was there meaningful human review?

Could affected persons challenge erroneous data or decisions?

Were the reasons for a restrictive measure documented?

The precise legal consequences depend on the applicable legislation and the nature of the decision.

4. Leading case laws

The following decisions establish principles relevant to biosurveillance accountability. Some concern DNA databases or digital surveillance rather than public-health surveillance directly; their application to biosurveillance is therefore analogical, not a claim that the courts decided the exact issue.

Case 1: Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

Supreme Court of India · (2017) 10 SCC 1

Facts and issue: A nine-judge Constitution Bench considered whether privacy is a fundamental right under the Indian Constitution, in proceedings arising from challenges involving the Aadhaar identity system.

Decision: The Court unanimously recognised privacy as a constitutionally protected fundamental right, rooted in Article 21 and other constitutional freedoms. The judgment also recognised informational privacy and the risks created by the collection, aggregation, and use of personal data.

Indian Kanoon+1

Principles relevant to biosurveillance:

State interference with privacy requires a lawful basis.

The measure must pursue a legitimate state objective.

Proportionality must be assessed between the objective and the means adopted.

Privacy protection includes positive obligations to establish safeguards against misuse.

Application: If a government combines patient records, pathogen test results, genomic information, and location data to identify individuals or impose restrictions, the system must be assessed against applicable constitutional standards.

A broad assertion that surveillance is useful for disease control is not, by itself, a complete justification for unrestricted collection or indefinite retention.

Accountability significance: Puttaswamy provides a central constitutional framework for challenging disproportionate or inadequately safeguarded health-data surveillance in India.

Case 2: S. and Marper v. United Kingdom (2008)

European Court of Human Rights · Applications Nos. 30562/04 and 30566/04 · Grand Chamber

Facts: The applicants challenged the retention of their fingerprints, DNA profiles, and cellular samples after criminal proceedings against them had ended without conviction.

Decision: The European Court of Human Rights found a violation of Article 8 of the European Convention on Human Rights, which protects private life. The blanket and indiscriminate retention regime was disproportionate. The Court emphasised the particularly sensitive nature of biological samples and genetic information.

Bailii+1

Legal principles:

Genetic information is highly sensitive personal information.

Retention can interfere with privacy even if no immediate harm has occurred.

Indefinite retention without sufficient differentiation or review can be disproportionate.

Safeguards must account for the nature of the information and the purpose for which it was collected.

Application to biosurveillance: A national pathogen-surveillance programme that collects human genomic samples or identifiable clinical specimens should distinguish between the public-health need for pathogen sequencing and the unnecessary retention of human genetic material or identifiable records.

The case does not prohibit all biological databases. Rather, it supports scrutiny of retention policies, purpose restrictions, access controls, and deletion criteria.

Accountability significance: Institutions should be able to explain why biological data is retained, for how long, and under what conditions it can be reused.

Case 3: Big Brother Watch and Others v. United Kingdom (2021)

European Court of Human Rights · Grand Chamber · Applications Nos. 58170/13, 62322/14 and 24960/15

Facts: The applicants challenged aspects of the United Kingdom's bulk interception and intelligence-sharing surveillance systems.

Decision: The Court identified fundamental deficiencies in aspects of the bulk-interception regime, including shortcomings in independent authorisation and safeguards governing selectors associated with identifiable individuals. It stressed the importance of safeguards across the entire surveillance process.

HUDOC+1

Legal principles:

Surveillance safeguards must cover the entire process, not merely initial collection.

Independent authorisation and oversight can be important protections against abuse.

The greater the intrusion into private life, the more carefully the system's safeguards must be assessed.

Application to biosurveillance: These principles are relevant when public-health agencies share data across government departments, private analytics providers, or international partners.

For example, a database initially created to monitor an infectious disease should not automatically become available for unrelated law-enforcement, immigration, or employment purposes without a valid legal basis and appropriate safeguards.

Accountability significance: The case supports end-to-end oversight of collection, analysis, sharing, retention, and secondary use. It does not establish that every public-health surveillance programme requires a judicial warrant; that question depends on the governing legal regime and the nature of the interference.

Case 4: Carpenter v. United States (2018)

Supreme Court of the United States · 585 U.S. 296 (2018)

Facts: Law-enforcement authorities obtained historical cell-site location information from telecommunications providers, revealing extensive records of the defendant's movements.

Decision: The US Supreme Court held that government acquisition of the historical location records at issue constituted a Fourth Amendment search and generally required a warrant supported by probable cause. The Court treated comprehensive digital location records differently from ordinary third-party business records.

LII / Legal Information Institute

Legal principles:

Aggregated digital data can reveal intimate patterns of personal life.

The fact that a third party holds information does not necessarily eliminate privacy protection.

The scale and depth of data collection can matter when assessing constitutional safeguards.

Application to biosurveillance: Location information linked with symptom reports, clinic visits, testing facilities, or infection status can reveal sensitive health patterns even if each individual data point appears innocuous.

The case is not a direct ruling on health surveillance, and its warrant requirement arises under US constitutional law. Nevertheless, it illustrates why linked and longitudinal datasets may require stronger protections than isolated records.

Accountability significance: Data controllers and public authorities should assess the combined information revealed by a dataset, not merely the apparent sensitivity of each field in isolation.

Case 5: Selvi v. State of Karnataka (2010)

Supreme Court of India · (2010) 7 SCC 263

Facts: The case concerned the involuntary administration of narco-analysis, polygraph examinations, and brain electrical activation profile tests to persons accused of offences.

Decision: The Supreme Court held that the involuntary administration of the techniques in question violated constitutional protections, including the right against self-incrimination under Article 20(3) and personal liberty under Article 21. The Court addressed bodily integrity, mental privacy, and the constitutional limits of compelled investigative techniques.

Relevance to biosurveillance: The judgment did not decide the legality of epidemiological monitoring or pathogen sequencing. Its reasoning is nevertheless relevant where a proposed surveillance system moves beyond ordinary public-health data collection into compelled bodily or cognitive examination.

For example, a compulsory programme involving biological sampling, intrusive testing, or compelled disclosure of highly personal information raises questions about statutory authority, consent, bodily integrity, and constitutional safeguards.

Accountability significance: Public-health authorities should distinguish routine, lawfully authorised disease monitoring from intrusive procedures that require additional constitutional justification.

Case 6: K.S. Puttaswamy (Aadhaar-5J.) v. Union of India (2018)

Supreme Court of India · (2019) 1 SCC 1 · Aadhaar judgment

Facts: The Court examined the constitutional validity of the Aadhaar framework, including questions about data collection, authentication, storage, privacy, and the use of identity infrastructure to deliver services.

Decision: The Court upheld parts of the Aadhaar framework while invalidating or limiting other provisions, including aspects of compulsory use and private-entity access. The judgment illustrates that the legitimacy of a system's objective does not automatically validate every method of implementation.

Sci API

Application to biosurveillance: A health-data platform may have a legitimate objective while still creating excessive risks if it links disease information to a universal identity system, permits broad secondary use, or makes essential services dependent on an intrusive data-processing arrangement.

Accountability significance: Identity-linked health surveillance should be examined for necessity, proportionality, access restrictions, exclusion risks, and available alternatives.

5. Indian statutory framework

For biosurveillance programmes operating in India, several legal frameworks may apply simultaneously.

The precise interaction between these instruments must be assessed for the particular programme. A statutory power to collect public-health information does not necessarily authorise every subsequent disclosure, indefinite retention, or unrelated use.

The Digital Personal Data Protection Act, 2023, should not be treated as if every provision necessarily applies to every entity or has the same commencement date. The relevant rules, commencement notifications, exemptions, and sector-specific requirements must be checked for the date and circumstances in question.

6. Who is accountable?

Accountability is often distributed among several actors, but shared responsibility should not become an excuse for having no identifiable decision-maker.

Government and public-health authorities

Must act within their statutory powers, justify restrictive measures, maintain appropriate safeguards, and provide lawful review mechanisms.

Laboratories and research institutions

Must comply with applicable sampling, consent, quality-control, confidentiality, recordkeeping, and research-ethics requirements.

AI developers and analytics providers

May bear contractual, statutory, professional, or other legal duties concerning security, model performance, documentation, and their role in processing data.

Hospitals and healthcare providers

Must comply with applicable confidentiality, recordkeeping, patient-safety, and data-protection obligations. They may also need to correct inaccurate information and investigate unauthorised disclosures.

The allocation of liability depends on each party's actual role, control over the data and decisions, applicable statutory duties, contractual arrangements, and the evidence connecting the conduct to the harm.

7. Principal legal risks and accountability failures

A. Inaccurate outbreak predictions

An algorithm may incorrectly classify an area as a high-risk infection cluster because its data is incomplete, delayed, or unrepresentative.

Possible consequences include unnecessary restrictions, reputational harm, and misallocation of medical resources.

Accountability requires documented validation, transparent uncertainty estimates, correction procedures, and review of consequential decisions.

B. Discriminatory surveillance

If surveillance disproportionately targets particular geographic, socioeconomic, or demographic groups without adequate justification, it may raise constitutional equality and privacy concerns.

In India, Article 14 is particularly relevant to challenges alleging arbitrary or discriminatory government action. A claimant would still need to establish the applicable legal grounds and supporting facts.

C. Unauthorised secondary use

Information gathered for disease prevention may subsequently be used for employment screening, insurance decisions, immigration enforcement, or unrelated policing.

Such reuse is not automatically lawful simply because the original collection was legitimate. Its permissibility depends on the applicable statute, purpose restrictions, exemptions, and other legal safeguards.

D. Data breaches and re-identification

Genomic and location-linked data can be identifying even when names have been removed. A breach may expose health conditions, family relationships, or other sensitive information.

Potential consequences include regulatory proceedings, contractual claims, professional discipline, or civil liability, depending on the governing law and circumstances.

E. Failure to detect a genuine outbreak

Accountability also operates in the opposite direction. If a responsible authority negligently ignores credible warnings, fails to follow applicable duties, or operates a materially defective surveillance system, the omission may warrant investigation.

However, a missed outbreak does not automatically establish legal liability. A claimant may need to prove a relevant duty, breach, causation, and legally recognised harm.

8. Practical accountability framework for biosurveillance systems

A responsible biosurveillance programme should implement the following controls.

Accountability checklist

0 of 8

Legal authorisation

Identify the statutory power, responsible authority, permitted purpose, and applicable exemptions before collecting data.

Data minimisation

Collect only the information reasonably needed for the specified surveillance objective.

Scientific validation

Document dataset limitations, model accuracy, uncertainty, false positives, and independent validation results.

Human oversight

Require appropriate review before high-impact decisions such as compulsory isolation or denial of essential services.

Security and access control

Use encryption, role-based access, audit logs, incident response, and safeguards for data transfers.

Retention and deletion

Establish retention periods, review continued necessity, and securely delete information when legally permissible and no longer needed.

Independent audit

Periodically assess legality, security, discriminatory outcomes, scientific performance, and compliance with approved purposes.

Complaints and remedies

Provide a practical route to correct errors, challenge decisions, report misuse, and seek appropriate legal relief.

Copy checklist

This checklist is a governance aid, not a substitute for a jurisdiction-specific legal compliance assessment.

9. Remedies for unlawful or defective biosurveillance

The appropriate remedy depends on who conducted the surveillance and what went wrong.

In India, constitutional remedies may include proceedings under Articles 32 or 226 where their requirements are satisfied. Other complaints may be brought before the relevant statutory, regulatory, or professional authority.

A breach of privacy or a defective algorithm does not automatically entitle every affected person to damages. The relevant cause of action, legal standing, statutory remedy, causation, and evidence must be established.

10. International public-health considerations

Data-driven biosurveillance often involves international sharing of pathogen sequences, outbreak alerts, and epidemiological information. This creates additional questions:

Which country or institution controls the data?

Can the receiving country identify individuals?

Are there restrictions on onward transfers and secondary use?

Who investigates a cross-border security incident?

How are research benefits, access, and community interests addressed?

The International Health Regulations (2005), as amended where applicable, provide an international framework for public-health surveillance, notification, and response. They should be read alongside domestic privacy laws, applicable international human-rights obligations, and relevant agreements.

International public-health cooperation does not itself eliminate domestic accountability. The precise obligations depend on the instrument, the parties, and the data-sharing arrangement.

11. Critical legal analysis

Three competing interests must be balanced.

First, public-health effectiveness. Rapid access to reliable data can enable earlier outbreak detection, improve resource allocation, and reduce preventable harm.

Second, individual and collective rights. Excessive surveillance can undermine confidentiality, discourage people from seeking treatment, stigmatise communities, and enable unrelated state or commercial uses.

Third, institutional responsibility. Scientific uncertainty is unavoidable, but institutions should document how they manage it. A prediction that proves incorrect is not necessarily unlawful; concealing known limitations, ignoring applicable duties, or imposing unjustified restrictions may present distinct legal problems.

The strongest accountability model combines lawful authority, scientifically sound methods, independent oversight, proportionate data use, transparent decision-making, and meaningful remedies.

12. Conclusion

Data-driven biosurveillance accountability is the principle that the public-health value of data cannot eliminate the legal responsibility of the institutions that collect, analyse, share, and act on it.

The most relevant judicial foundations include Puttaswamy for Indian constitutional privacy, S. and Marper for the sensitive nature and retention of biological data, Big Brother Watch for end-to-end surveillance safeguards, Carpenter for the privacy implications of aggregated digital records, and Selvi for constitutional limits on certain intrusive investigative techniques.

These cases do not establish a single, universal biosurveillance liability rule. Instead, they supply principles that courts and policymakers can apply to particular systems, alongside the governing statutory framework.

For India, the central legal task is to ensure that disease surveillance remains scientifically reliable, lawfully authorised, proportionate, secure, and open to independent scrutiny. The phased commencement of the Digital Personal Data Protection Act, 2023, under the November 2025 notification also means that the operative provisions must be checked for the date of the relevant conduct.

E-Gazette+1

This is a general legal research overview, not an opinion on a specific surveillance programme or dispute.